We are live on ! Find out more
IE

Israel Englander Millennium Management

AUM $276B
1-Year Est. Return 44.8%
 

Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.

This Fund
S&P 500
This Quarter Est. Return
-0.14%
1 Year Est. Return
+44.8%
3 Year Est. Return
+127.22%
5 Year Est. Return
+155.52%
10 Year Est. Return
+768.06%
AUM
$167B
AUM Growth
+$3.7B
Cap. Flow
-$692M
Cap. Flow %
-0.42%
Top 10 Hldgs %
18.31%
Holding
7,698
New
1,245
Increased
2,719
Reduced
2,446
Closed
981

Sector Composition

Rank Sector Weight
1 Miscellaneous 58.05%
2 Technology 7.69%
3 Financials 6.83%
4 Healthcare 6.42%
5 Industrials 4.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GALT icon
4301
Galectin Therapeutics
GALT
$405M
$1.36M ﹤0.01%
350,336
-218,354
-38% -$740K
CLRMU
4302
DELISTED
Clarim Acquisition Corp. Unit
CLRMU
$1.36M ﹤0.01%
137,884
-359,799
-72% -$3.57M
ALLT icon
4303
Allot
ALLT
$381M
$1.36M ﹤0.01%
91,281
-122,056
-57% -$2.07M
APTV icon
4304
PUT
Aptiv
APTV
$9.5B
$1.36M ﹤0.01%
+9,100
New +$1.42M
NERV icon
4305
Minerva Neurosciences
NERV
$231M
$1.36M ﹤0.01%
97,428
-64,378
-40% -$968K
SRCL
4306
DELISTED
Stericycle Inc
SRCL
$1.35M ﹤0.01%
19,932
-63,412
-76% -$4.38M
MASI
4307
PUT
DELISTED
Masimo
MASI
$1.35M ﹤0.01%
5,000
-15,000
-75% -$4.07M
COVA
4308
DELISTED
COVA Acquisition Corp. Class A Ordinary Share
COVA
$1.35M ﹤0.01%
138,832
-3,150
-2% -$30.5K
GBTG icon
4309
CALL
American Express Global Business Travel
GBTG
$4.95B
$1.35M ﹤0.01%
1,660,140
-36,492
-2% -$356K
FNCB
4310
DELISTED
FNCB Bancorp Inc. Common Stock
FNCB
$1.35M ﹤0.01%
162,434
-123,294
-43% -$952K
MTCH icon
4311
Match Group
MTCH
$9.54B
$1.35M ﹤0.01%
8,582
-594,995
-99% -$90.6M
IBER.U
4312
DELISTED
Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant
IBER.U
$1.35M ﹤0.01%
134,735
-195,383
-59% -$1.95M
TRS icon
4313
TriMas Corp
TRS
$1.42B
$1.35M ﹤0.01%
41,589
-209,854
-83% -$6.48M
GLBLU
4314
DELISTED
Cartesian Growth Corporation Unit
GLBLU
$1.35M ﹤0.01%
132,211
-488,191
-79% -$4.87M
PR
4315
Permian Resources
PR
$19B
$1.34M ﹤0.01%
200,752
-1,743,200
-90% -$9.5M
CYBR
4316
CALL
DELISTED
CyberArk
CYBR
$1.34M ﹤0.01%
+8,500
New +$1.29M
SENS icon
4317
Senseonics Holdings Inc
SENS
$493M
$1.34M ﹤0.01%
19,778
+2,355
+14% +$160K
PMT
4318
PennyMac Mortgage Investment
PMT
$814M
$1.34M ﹤0.01%
67,954
+18,829
+38% +$369K
BLNK icon
4319
Blink Charging
BLNK
$77.2M
$1.34M ﹤0.01%
46,735
-10,766
-19% -$349K
NVSAU
4320
DELISTED
New Vista Acquisition Corp Unit
NVSAU
$1.33M ﹤0.01%
133,776
-382,624
-74% -$3.82M
CPLG
4321
DELISTED
CorePoint Lodging Inc. Common Stock
CPLG
$1.33M ﹤0.01%
85,946
+35,916
+72% +$496K
TGTX icon
4322
CALL
TG Therapeutics
TGTX
$8.26B
$1.33M ﹤0.01%
+40,000
New +$1.24M
ANIK icon
4323
Anika Therapeutics
ANIK
$282M
$1.33M ﹤0.01%
31,244
-13,208
-30% -$544K
SDC
4324
CALL
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
$1.33M ﹤0.01%
250,000
-150,000
-38% -$931K
MRLN
4325
DELISTED
Marlin Business Services Corp
MRLN
$1.33M ﹤0.01%
+59,807
New +$1.34M

Similar funds

Israel Englander's Q3 2021 Portfolio in Review

As of Q3 2021, Israel Englander held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Israel Englander's Q3 2021 filing shows 1,245 new, 2,719 increased, 2,446 reduced and 981 closed positions. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M. The largest sale was Alexion Pharmaceuticals, an estimated $887M.

By sector, the portfolio is most concentrated in Miscellaneous at 58% of assets, up from 55% a quarter earlier, followed by Technology and Financials.

  • Israel Englander's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
  • Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
  • Israel Englander's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
  • Israel Englander fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
  • Israel Englander's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
  • Israel Englander opened 1,245 new positions and closed 981 in Q3 2021.
  • Israel Englander's portfolio value rose 2.3% quarter-over-quarter to $167B.

Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.